SQI Diagnostics Inc. announced it has appointed Lennie Ryer CPA, CA, CFE to its Management team. In his capacity as CFO, he will assist the company in its transition from a development stage to a commercially successful company including strategic financing initiatives to advance the company's capital market strategy and to secure funding to drive future growth and further expansion of SQI proprietary technologies. Mr. Ryer previously held the position of Chief Financial Officer and Vice-President of Finance at ConjuChem Biotechnologies Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -100.00% | -100.00% |
2023 | SQI Diagnostics Announces Resignation of Wilmot L. Matthews as Director | CI |
2023 | Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc | CI |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 4.49M | |
+11.98% | 228B | |
+14.46% | 196B | |
+17.93% | 141B | |
+28.42% | 110B | |
+0.53% | 65.88B | |
+16.54% | 54.3B | |
+6.33% | 52.39B | |
+11.26% | 45.22B | |
+5.11% | 37.12B |
- Stock Market
- Equities
- SQD.H Stock
- News SQI Diagnostics Inc.
- SQI Diagnostics Inc. Appoints Lennie Ryer as CFO